Browsing the "medicine" Tag

Emergen-C

September 16th, 2014

June 2014: A superior court judge gave final approval of the settlement to this lawsuit. December 2013: A superior court


Excedrin Migraine

January 22nd, 2014

In January 2014, a class-action lawsuit filed against Novartis Consumer Health over its marketing and pricing of Excedrin Migraine was


Vioxx

October 17th, 2013

In August 2013, a federal judge preliminarily approved a $23 million settlement to a class-action lawsuit filed against Merck Sharp


Earache Medicines

September 25th, 2013

The FDA sent warning letters to four earache medication makers demanding that the companies stop marketing their products, which the


Tylenol

September 23rd, 2013

A new in-depth report by ProPublica and This American Life is questioning Tylenol's safety and labeling.


Rebranded Drugs

August 13th, 2013

Some drugs are the same except for their names and packaging. For example: Sarafem, marketed as a treatment for Premenstrual


SmartPractice

June 6th, 2013

According to a warning letter from the FDA, the Danish company, SmartPractice, promoted an allergic contact dermatitis test kit called


Potiga

June 5th, 2013

The FDA has warned consumers that anti-seizure medication Potiga can cause blue discoloration of the skin and pigment changes in


Misleading Drug Marketing Might Just Kill You

January 4th, 2013

Amgen, the world’s largest biotechnology company that made billions marketing its anemia drug Aranesp for unapproved uses, agreed to pay $762 million to settle off-use marketing charges.



Back to Top ↑